#Sweden #Gothenburg #revenue growth #Faun Pharma #Zinzino Group

Zinzino AB Reports 20% Increase in January Revenue

Swedish company Zinzino AB released its preliminary sales report for January 2026, showcasing a significant 20% growth in group revenue compared to the same month in the previous year. The total revenue for Zinzino's sales markets amounted to SEK 274.1 million, an increase from SEK 229.2 million in January 2025. In addition, the subsidiary Faun Pharma experienced an increase in external sales, recording SEK 7.1 million, which is substantially higher than the SEK 4.7 million reported during the same month last year.

Overall, the Zinzino Group’s total revenue reached SEK 281.2 million, up from SEK 233.9 million in January 2025. This positive trend demonstrates Zinzino's increasing market presence and customer engagement in various regions.

Revenue Breakdown by Region

The completion of the report includes a detailed breakdown of revenues across various regions, illustrating where the growth has been most substantial:

• - The Nordics: SEK 27.3 million (up from SEK 25.9 million, a 5% increase)
• - Central Europe: SEK 90.1 million (up from SEK 69.4 million, a substantial 30% increase)
• - East Europe: SEK 29.4 million (down from SEK 34.2 million, a decline of 14%)
• - South West Europe: SEK 46.6 million (up from SEK 44.1 million, a 6% increase)
• - The Baltics: SEK 10.5 million (up slightly from SEK 10.4 million)
• - North America: SEK 41.3 million (a remarkable increase from SEK 21.3 million, representing a 94% growth)
• - South America: SEK 4 million (up drastically from SEK 0.9 million, a whopping 344% increase)
• - Asia-Pacific: SEK 23 million (up from SEK 21.5 million, a 7% increase)
• - Africa: SEK 1.9 million (up from SEK 1.5 million, a 27% increase)

Overall, this diverse growth across regions highlights Zinzino's expanding footprint in new and existing markets. Especially notable is the soaring success in North America, where Zinzino has seen nearly doubling sales, and the astounding growth in South America indicating newfound momentum in these markets.

Future Outlook

As Zinzino continues to innovate and expand its product offerings, it shows a promising trajectory for further growth. The beverage and health product markets are evolving, and with Zinzino's strategic focus, the company appears poised to capture even more market share. Future reports will be closely monitored by investors and market analysts alike to see how the company builds on this success.

Zinzino's CEO, Dag Bergheim Pettersen, and CFO, Fredrik Nielsen, are committed to sharing more insights into the company’s operational strategies and future direction as they navigate the challenging and changing market landscape.

Overall, Zinzino's robust January sales figures not only reflect the company's strong performance but also indicate a healthy confidence in its ongoing strategies and product lines.